TENURE AND SENIORITY Sample Clauses

TENURE AND SENIORITY. Job Share participants will retain their tenure and seniority. Two (2) years in a Job Share will equal one (1) year increase on the seniority schedule.
AutoNDA by SimpleDocs
TENURE AND SENIORITY. A. Employees eligible for statutory tenure shall receive this entitlement consistent with the statutory provisions.
TENURE AND SENIORITY. A. All bargaining unit members with more than three (3) years continuous service in the District as a custodial or maintenance employee as of July 1, 1993, shall be appointed to indefinite terms and thereby receive tenure. All other bargaining unit members, after the expiration of a period of employment of three (3) consecutive calendar years in the District as custodial or maintenance employee (an academic year beginning the period between the time when school opens in the District after the general summer vacation and the beginning of the next succeeding summer vacation), shall hold their employment under tenure during good behavior and efficiency.
TENURE AND SENIORITY. A. Tenure Effective with the execution of this Agreement, members of the unit covered by Section 75 of the Civil Service Law shall be subject to disciplinary action pursuant to this Article in lieu of Section 75. Employees in the non-competitive and labor classes who have been employed for 18 months or more shall not be suspended or discharged without just cause. Alleged violations of this provision shall be subject to the grievance procedure, provided, however, for purposes of alleged violations of this subsection only, the decision of the arbitrator shall be final and binding. For those employees in the competitive classifications, this provision shall be applicable upon completion of their probationary period.
TENURE AND SENIORITY. A. 1. All unit members who were tenured prior to July 1, 2006 shall be tenured. Non-tenured full time teachers hired after July 1, 2014 will be considered tenured after a period of four (4) years and one (1) day unless the teacher is notified by May 1st of his/her fourth year of service that based on his/her evaluations an extension of one (1) year will be required.
TENURE AND SENIORITY. The parties acknowledge that the Superintendent has tenure in the position of principal as well as other positions in the district. Throughout this contract, the Superintendent shall retain all tenure rights in all prior positions, and shall continue to accrue seniority in the position of principal and all other tenured positions. In the event that the Superintendent’s contract is not renewed or if she resigns from the position of Superintendent, she shall be permitted to assert her tenure and seniority rights, including bumping rights, to the position of principal in the district. The Superintendent shall also continue to advance on the Principal’s salary guide throughout the term of this contract. During the 2017-2018 school year, the Superintendent was assigned as principal Step 17, if assigned principal during the 2020 school year, she would be assigned to step 20 during the 2020 school year.
TENURE AND SENIORITY. The parties acknowledge that the Superintendent has attained tenure from multiple prior positions within the district. Throughout the term of this contract as well as any successor contract, the Superintendent shall retain all tenure rights and continue to accrue seniority in all such prior positions. In the event the Superintendent is not renewed, or in the event that she resigns by providing 90-days’ notice, she shall be entitled to assert all “bumping” rights by virtue of her tenure and seniority rights.
AutoNDA by SimpleDocs
TENURE AND SENIORITY 

Related to TENURE AND SENIORITY

  • NATURE AND SCOPE 4.1 This Agreement is an agreement under the terms and conditions of which the Supplier/Service Provider will arrange for the supply/provision to Transnet of the Goods/Services which meet the requirements and specifications of Transnet, the delivery of which is controlled by means of Purchase Orders to be issued by Transnet and executed by the Supplier/Service Provider in accordance with this Agreement.

  • Nature and Scope of Guaranty 1.1 The Guarantor, jointly and severally (if executed by more than one person), irrevocably, absolutely and unconditionally guarantees to the Lender, its successors and assigns, the payment of the Debt and the payment and performance of all the Obligations, subject to the recourse limitations of Paragraphs 8 and 9 of the Note. This Guaranty is a primary and absolute obligation of the Guarantor.

  • Disclosure and Use 20.2.1 Each Receiving Party agrees that, from and after the Effective Date:

  • Procedure and Effect of Termination In the event of termination and abandonment of the transactions contemplated hereby pursuant to Section 9.1, written notice thereof shall forthwith be given to the other parties to this Agreement and this Agreement shall terminate and the transactions contemplated hereby shall be abandoned, without further action by any of the parties hereto. If this Agreement is terminated as provided herein:

  • PROFESSORS, TEACHERS AND RESEARCHERS 1. An individual who is a resident of a Contracting State immediately before making a visit to the other Contracting State, and who, at the invitation of any university, college, school or other similar educational institution which is recognized by the competent authority in that other Contracting State, visits that other Contracting State for a period not exceeding two years solely for the purpose of teaching or research or both at such educational institution shall be exempt from tax in that other Contracting State on any remuneration for such teaching or research.

  • LICENSURE AND CERTIFICATION 25.1 The Employer will continue its current practices related to licensure and certification.

  • Disclosure and Use Restrictions The Executive agrees and covenants: (i) to treat all Confidential Information as strictly confidential; (ii) to not use Confidential Information except for the benefit of the Company; (iii) not to directly or indirectly disclose, publish, communicate, or make available Confidential Information, or allow it to be disclosed, published, communicated, or made available, in whole or part, to any entity or person whatsoever (including other employees of the Company) not having a need to know and authority to know and use the Confidential Information in connection with the business of the Company and, in any event, not to anyone outside of the direct employ of the Company except as required in the performance of the Executive’s authorized employment duties to the Company or with the prior consent of the Board (and then, such disclosure shall be made only within the limits and to the extent of such duties or consent); and (iii) not to access or use any Confidential Information, and not to copy any documents, records, files, media, or other resources containing any Confidential Information, or remove any such documents, records, files, media, or other resources from the premises or control of the Company, except as required in the performance of the Executive’s authorized employment duties to the Company or with the prior consent of the Board (and then, such disclosure shall be made only within the limits and to the extent of such duties or consent). Nothing herein shall be construed to prevent disclosure of Confidential Information as may be required by applicable law or regulation, or pursuant to the valid order of a court of competent jurisdiction or an authorized government agency, provided that the disclosure does not exceed the extent of disclosure required by such law, regulation, or order. The Executive shall promptly provide written notice of any such order to the Board.

  • Capital Structure and Business If all or part of a Credit Party's Stock is pledged to Agent, that Credit Party shall not issue additional Stock. No Credit Party shall amend its charter or bylaws in a manner that would adversely affect Agent or Lenders or such Credit Party's duty or ability to repay the Obligations. No Credit Party shall engage in any business other than the businesses currently engaged in by it or businesses reasonably related thereto.

  • Number, Tenure and Qualifications The number of managers of the Company shall be not less than one (1) nor more than ten (10), but may be increased by amendment of this LLC Agreement by the Members. Each manager shall hold office for the term of which he is elected or until his successor shall have been elected and qualifies for the office, whichever period is longer. Managers need not be residents of the state of formation nor need they be the holder of any Percentage Ownership of the Company.

  • Manufacture and Supply BMS shall Manufacture or have Manufactured the BMS Study Drug in reasonable quantities needed, and at the points in time as agreed to by the Parties, for the Combined Therapy Clinical Trial, and shall supply such BMS Study Drug as either commercially labeled or unlabeled vials to the Recipient or its designee for use solely in the Combined Therapy Clinical Trial. The Recipient will at its sole expense, package and label the BMS Study Drug for use in the Combined Therapy Clinical Trial to the extent necessary. The cost of Manufacture and supply (including shipping, taxes and duty, if applicable) of the BMS Study Drug for the Combined Therapy Clinical Trial shall be borne solely by BMS, and BMS shall bear the risk of loss for such quantities of BMS Study Drug until delivery of such quantities of BMS Study Drug to the Recipient or its designee. BMS shall also be responsible for the payment of any Third Party License Payments that may be due based on the manufacture, *CONFIDENTIAL TREATMENT REQUESTED. supply and use of the BMS Study Drug used in the Combined Therapy Clinical Trial. The BMS Study Drug shall be manufactured in accordance with Applicable Law (including GMP) and shall be of similar quality to the BMS Study Drug used by BMS for its other clinical trials of the BMS Study Drug. BMS shall deliver certificates of analysis, and any other documents specified in the Supply and Quality Documentation, including such documentation as is necessary to allow the Recipient to compare the BMS Study Drug certificate of analysis to the BMS Study Drug specifications. Pursuant to the Supply and Quality Documentation, BMS shall be responsible for the regulatory compliance of the quality of the BMS Study Drug at the time the BMS Study Drug is delivered to the Recipient with the regulatory filings in the countries in the Territory where the Combined Therapy Clinical Trial will be performed. Subject to Section 4.4, the Parties shall cooperate in accordance with Applicable Law to minimize indirect taxes (such as value added tax, sales tax, consumption tax and other similar taxes) relating to the BMS Study Drug in connection with this Agreement.

Time is Money Join Law Insider Premium to draft better contracts faster.